Funding Opportunities

• Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
  (PAR-20-055)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 5, 2020.
• Surgical Disparities Research (R01 - Clinical Trial Optional)
  (PAR-20-079)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  Application Receipt Date(s): New Applications: June 5, 2020,; June 5, 2021, June 5, 2022. Resubmission/revision applications: July 5, 2020, July 5, 2021, July 5, 2022.
• Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
  (PAR-20-082)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 16, 2020.
• Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required)
  (RFA-DK-19-021)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 26, 2020
• Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)
  (RFA-DK-19-024)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 1, 2020
• New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
  (RFA-DK-19-026)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 25, 2020 and November 3, 2020
• Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional)
  (RFA-DK-19-029)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 7, 2020
• BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional)
  (RFA-NS-20-006)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): March 24, 2020, June 2, 2020, October 1, 2020, February 2, 2021, June 1, 2021, February 1, 2022, and October 3, 2022
• White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed)
  (RFA-NS-20-013)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): June 30, 2020